Showing results (1581-1590 of 1,712) with videos related to
Sort By:
Pageof 172
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|June 30, 2026
Infection prevention and control of <i>Candida auris</i> in pediatric settingsThomas S Murray, Hana Hakim, Christelle Ilboudo, et al.Investigational New Drugs|May 4, 2005
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulamCharlotte van Kesteren, Anthe S Zandvliet, Mats O Karlsson, et al.Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Integration of dilated cardiomyopathy genomics with transcriptomics from the human heart implicates regulatory molecular mechanismsConnor S Murray, Chaojie Yang, Suet Nee Chen, et al.Hypertension (Dallas, Tex. : 1979)|October 26, 2011
Genetic variants and blood pressure in a population-based cohort: the Cardiovascular Risk in Young Finns studyMervi Oikonen, Emmi Tikkanen, Jonna Juhola, et al.American Journal of Respiratory and Critical Care Medicine|July 31, 2023
Circulating CC16 and Asthma: A Population-based, Multicohort Study from Early Childhood through Adult LifeNipasiri Voraphani, Debra A Stern, Julie G Ledford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2025
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 StudySiamak Daneshmand, Michiel S Van der Heijden, Joseph M Jacob, et al.Neuropsychology|November 14, 2013
The NIH Toolbox Cognition Battery: results from a large normative developmental sample (PING)Natacha Akshoomoff, Erik Newman, Wesley K Thompson, et al.Plos One|February 2, 2012
Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--a meta-analysis of three independent studiesJussi A Hernesniemi, Ilkka Seppälä, Leo-Pekka Lyytikäinen, et al.Urologic Oncology|July 30, 2023
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumorsJoseph M Jacob, Solomon L Woldu, Jennifer Linehan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJ C Soria, H K Gan, S P Blagden, et al.Pageof 172